Moody Aldrich Partners LLC Ventyx Biosciences, Inc. Transaction History

Moody Aldrich Partners LLC

  • $503 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
BUY
$29.8 - $40.3 $44,431 - $60,087
1,491 Added 4.09%
37,988 $1.32 Million
Q2 2023

Jul 28, 2023
SELL
$28.53 - $39.55 $1,512 - $2,096
-53 Reduced 0.15%
36,497 $1.2 Million
Q1 2023

Apr 27, 2023
SELL
$29.51 - $46.65 $1.26 Million - $1.99 Million
-42,700 Reduced 53.88%
36,550 $1.22 Million
Q4 2022

Jan 23, 2023
BUY
$24.16 - $36.38 $1.91 Million - $2.88 Million
79,250 New
79,250 $0

Others Institutions Holding VTYX

# of Institutions
125
Shares Held
52.9M
Call Options Held
35.3K
Put Options Held
83K
View Full List

About Ventyx Biosciences, Inc.

VTYX Quotes by TradingView
  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $132M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email